Linked Life Data

10796785

Source:http://linkedlifedata.com/resource/pubmed/id/10796785

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-7-6
pubmed:abstractText
The majority of epileptic patients have a good prognosis and their seizures can be well controlled with the use of a single antiepileptic agent, but up to 30% develop refractory epilepsy, especially those with partial seizures. In this review we summarise the current evidence regarding a new antiepileptic drug, gabapentin, when used as an add-on treatment for drug-resistant partial epilepsy
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD001415
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Gabapentin for drug-resistant partial epilepsy.
pubmed:affiliation
University Department of Neurological Science, The University of Liverpool, The Walton Centre for Neurology & Neurosurgery, Lower Lane, Fazakerley, Liverpool, Merseyside, UK, L9 7LJ. TMarson@compuserve.com
pubmed:publicationType
Journal Article, Review